Copyright
©The Author(s) 2025.
World J Hepatol. Feb 27, 2025; 17(2): 101741
Published online Feb 27, 2025. doi: 10.4254/wjh.v17.i2.101741
Published online Feb 27, 2025. doi: 10.4254/wjh.v17.i2.101741
Table 9 Analysis of cytokine results in the two groups
| Immunity | DILI (n = 31) | DILI + NAFL (n = 39) | P value |
| Interferon (pg/mL) | 1.46 (0.67, 3.43) | 2.29 (1.58, 3.14) | 0.149 |
| Tumor necrosis factor (pg/mL) | 0.86 (0.48, 1.48) | 1.09 (0.62, 2.27) | 0.163 |
| IL-2 (pg/mL) | 0 (0, 0.93) | 0.4 (0, 2.56) | 0.092 |
| IL-4 (pg/mL) | 0.56 (0.28, 1.69) | 1.6 (0.82, 2.69) | 0.007 |
| IL-6 (pg/mL) | 4.65 (1.82, 6.39) | 5.11 (2.79, 9.54) | 0.144 |
| IL-10 (pg/mL) | 4.16 (2.85, 11.95) | 4.28 (2.22, 9.91) | 0.92 |
| IL-17 (pg/mL) | 0.91 (0.38, 1.95) | 1.1 (0.6, 2.35) | 0.274 |
- Citation: Zhao Y, Li JZ, Liu YG, Zhu YJ, Zhang Y, Zheng WW, Ma L, Li J, Wang CY. Clinical features and prognosis of drug-induced liver injury in patients with non-alcoholic fatty liver. World J Hepatol 2025; 17(2): 101741
- URL: https://www.wjgnet.com/1948-5182/full/v17/i2/101741.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i2.101741